World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
21036
World Ranking
18462
National Ranking
99

Overview

Roy M. Bremnes is affiliated with the University of Tromsø - The Arctic University of Norway. Their research focuses primarily on medicine and biochemistry, genetics, and molecular biology, with particular attention to cancer research, molecular biology, oncology, surgery, and pulmonary and respiratory medicine.

The main topics addressed in Bremnes's work include testicular diseases and treatments, cancer immunotherapy and biomarkers, microRNA in disease regulation, circular RNAs in diseases, cancer-related molecular mechanisms, ovarian cancer diagnosis and treatment, and sexual differentiation and disorders.

Frequent coauthors in Bremnes's research collaborations include Thomas K. Kilvær, Sigve Andersen, Mehrdad Rakaee, Lill-Tove Busund, and Tom Dønnem.

Key publication venues for Bremnes include:

  • Scientific Reports
  • Journal of Clinical Oncology
  • British Journal of Cancer
  • Carcinogenesis
  • Annals of Oncology

Notable recent papers by Bremnes feature the following:

  • Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer (2021), published in British Journal of Cancer
  • High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients (2021), published in Scientific Reports
  • Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer? (2020), published in Carcinogenesis
  • Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study (2020), published in Journal of Clinical Oncology
  • High expression of microRNA-126 relates to favorable prognosis for colon cancer patients (2021), published in Scientific Reports

Best Publications

  • Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Michael V. Di Maria

  • Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

    Khalid I. Al-Shibli;Tom Donnem;Samer Al-Saad;Magnus Persson

  • The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.

    Roy M. Bremnes;Tom Dønnem;Samer Al-Saad;Khalid Al-Shibli

  • Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.

    Stein Sundstrøm;Roy M. Bremnes;Stein Kaasa;Ulf Aasebø

  • Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

    Hege S. Haugnes;Torgeir Wethal;Nina Aass;Olav Dahl

  • Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.

    Roy M. Bremnes;Carlos Camps;Rafael Sirera

  • The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.

    Roy M. Bremnes;Lill-Tove Busund;Thomas L. Kilvær;Sigve Andersen

  • High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer

    Roy M. Bremnes;R. Veve;E. Gabrielson;F. R. Hirsch

  • Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

    Bjørn H Grønberg;Roy M Bremnes;Oystein Fløtten;Tore Amundsen

  • The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

    Roy M. Bremnes;Khalid Al-Shibli;Tom Donnem;Rafael Sirera

  • The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis.

    Roy M. Bremnes;Robert Veve;Fred R. Hirsch;Wilbur A. Franklin

  • Paternity Following Treatment for Testicular Cancer

    Marianne Brydøy;Sophie D. Fosså;Olbjørn Klepp;Roy M. Bremnes

  • Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

    Torgrim Tandstad;Olav Dahl;Gabriella Cohn-Cedermark;Eva Cavallin-Stahl

  • Stromal CD8+ T Cell Density - A Promising Supplement to TNM staging in Non-Small Cell Lung Cancer

    Tom Donnem;Sigurd M Hald;Erna-Elise Paulsen;Elin Richardsen

  • Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

    Hege S. Haugnes;George J. Bosl;Hink Boer;Jourik A. Gietema

  • Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group

    Torgrim Tandstad;Rune Smaaland;Arne Solberg;Roy M. Bremnes

  • Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

    C von Plessen;B Bergman;O Andresen;RM Bremnes

  • The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

    Roy M Bremnes;Stein Sundstrom;Ulf Aasebø;Stein Kaasa

  • WNT7a induces E-cadherin in lung cancer cells.

    Tatsuo Ohira;Robert M. Gemmill;Kevin Ferguson;Sophie Kusy

  • Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.

    Carina Nord;Trine Bjøro;Dag Ellingsen;Arnstein Mykletun

Frequent Co-Authors

Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Tom Wilsgaard
Tom Wilsgaard University of Tromsø - The Arctic University of Norway
Tore Wentzel-Larsen
Tore Wentzel-Larsen Norwegian Centre for Violence and Traumatic Stress Studies
Stein Kaasa
Stein Kaasa Oslo University Hospital
Alv A. Dahl
Alv A. Dahl University of Oslo
Rafael Rosell
Rafael Rosell Autonomous University of Barcelona
Wilbur A. Franklin
Wilbur A. Franklin University of Colorado Denver
Hans-Olov Adami
Hans-Olov Adami Karolinska Institute
Arnstein Mykletun
Arnstein Mykletun Norwegian Institute of Public Health
Vickie E. Baracos
Vickie E. Baracos University of Alberta

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but want flexible options, a range of online degrees and alternative career pathways are available. For nursing professionals aiming to advance quickly, the quickest dnp program options let you earn your Doctor of Nursing Practice in record time, providing a fast track to leadership roles in healthcare.

Cost is another key consideration. Many institutions now offer affordable dnp programs that help reduce the financial burden, enabling more students to access advanced nursing education.

For those looking to enter the field quickly, fast track lpn programs provide a streamlined path into practical nursing, allowing you to gain hands-on experience sooner.

Mental health remains a growing field, and specialized programs such as online msn pmhnp programs are available online, preparing graduates for in-demand careers as Psychiatric-Mental Health Nurse Practitioners.

These online options can help you tailor your journey to fit your schedule, career goals, and budget, making medical education more accessible than ever.

Best Scientists Citing Roy M. Bremnes

Trending Scientists

Recently Published Articles